Annual Shareholders Equity
$23.28 M
-$12.10 M-34.20%
31 December 2023
Summary:
Cytosorbents annual stockholders equity is currently $23.28 million, with the most recent change of -$12.10 million (-34.20%) on 31 December 2023. During the last 3 years, it has fallen by -$55.94 million (-70.62%). CTSO annual shareholders equity is now -70.62% below its all-time high of $79.22 million, reached on 31 December 2020.CTSO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$13.00 M
-$3.74 M-22.33%
30 September 2024
Summary:
Cytosorbents quarterly stockholders equity is currently $13.00 million, with the most recent change of -$3.74 million (-22.33%) on 30 September 2024. Over the past year, it has dropped by -$5.51 million (-29.78%). CTSO quarterly shareholders equity is now -83.80% below its all-time high of $80.23 million, reached on 30 September 2020.CTSO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.2% | -29.8% |
| 3 y3 years | -70.6% | -81.6% |
| 5 y5 years | +37.4% | +93.0% |
CTSO Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -70.6% | at low | -81.6% | at low |
| 5 y | 5 years | -70.6% | +581.0% | -83.8% | +280.3% |
| alltime | all time | -70.6% | +263.2% | -83.8% | +191.1% |
Cytosorbents Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $13.00 M(-22.3%) |
| June 2024 | - | $16.74 M(-11.6%) |
| Mar 2024 | - | $18.93 M(-18.7%) |
| Dec 2023 | $23.28 M(-34.2%) | $23.28 M(+25.7%) |
| Sept 2023 | - | $18.51 M(-23.2%) |
| June 2023 | - | $24.09 M(-16.8%) |
| Mar 2023 | - | $28.96 M(-18.1%) |
| Dec 2022 | $35.38 M(-43.5%) | $35.38 M(-9.6%) |
| Sept 2022 | - | $39.14 M(-17.7%) |
| June 2022 | - | $47.56 M(-14.2%) |
| Mar 2022 | - | $55.43 M(-11.4%) |
| Dec 2021 | $62.58 M(-21.0%) | $62.58 M(-11.4%) |
| Sept 2021 | - | $70.61 M(-5.1%) |
| June 2021 | - | $74.39 M(-3.7%) |
| Mar 2021 | - | $77.26 M(-2.5%) |
| Dec 2020 | $79.22 M(+2217.6%) | $79.22 M(-1.3%) |
| Sept 2020 | - | $80.23 M(+229.9%) |
| June 2020 | - | $24.32 M(+14.1%) |
| Mar 2020 | - | $21.31 M(+523.6%) |
| Dec 2019 | $3.42 M(-79.8%) | $3.42 M(-49.2%) |
| Sept 2019 | - | $6.73 M(-41.7%) |
| June 2019 | - | $11.54 M(-23.1%) |
| Mar 2019 | - | $15.01 M(-11.3%) |
| Dec 2018 | $16.93 M(+65.0%) | $16.93 M(-15.6%) |
| Sept 2018 | - | $20.07 M(-6.9%) |
| June 2018 | - | $21.56 M(+49.2%) |
| Mar 2018 | - | $14.45 M(+40.8%) |
| Dec 2017 | $10.26 M(+667.3%) | $10.26 M(+8.3%) |
| Sept 2017 | - | $9.47 M(+19.7%) |
| June 2017 | - | $7.92 M(-604.0%) |
| Mar 2017 | - | -$1.57 M(-217.4%) |
| Dec 2016 | $1.34 M(-83.7%) | $1.34 M(-3.0%) |
| Sept 2016 | - | $1.38 M(-64.6%) |
| June 2016 | - | $3.90 M(-37.8%) |
| Mar 2016 | - | $6.26 M(-23.7%) |
| Dec 2015 | $8.21 M | $8.21 M(-12.2%) |
| Sept 2015 | - | $9.36 M(-19.1%) |
| June 2015 | - | $11.57 M(+19.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $9.67 M(+143.9%) |
| Dec 2014 | $3.96 M(-127.8%) | $3.96 M(-136.7%) |
| Sept 2014 | - | -$10.80 M(+17.0%) |
| June 2014 | - | -$9.23 M(+27.2%) |
| Mar 2014 | - | -$7.26 M(-49.1%) |
| Dec 2013 | -$14.27 M(+22.7%) | -$14.27 M(+4.8%) |
| Sept 2013 | - | -$13.61 M(+3.2%) |
| June 2013 | - | -$13.19 M(+10.5%) |
| Mar 2013 | - | -$11.94 M(+2.7%) |
| Dec 2012 | -$11.63 M(+15.2%) | -$11.63 M(-1074.9%) |
| Sept 2012 | - | $1.19 M(+101.4%) |
| June 2012 | - | $592.00 K(+10.6%) |
| Mar 2012 | - | $535.30 K(-105.3%) |
| Dec 2011 | -$10.09 M(+1982.1%) | -$10.09 M(-1000.1%) |
| Sept 2011 | - | $1.12 M(-41.5%) |
| June 2011 | - | $1.92 M(+66.6%) |
| Mar 2011 | - | $1.15 M(-337.5%) |
| Dec 2010 | -$484.60 K(-138.2%) | -$484.60 K(-47.8%) |
| Sept 2010 | - | -$927.50 K(+241.6%) |
| June 2010 | - | -$271.50 K(-173.9%) |
| Mar 2010 | - | $367.40 K(-71.0%) |
| Dec 2009 | $1.27 M(-46.3%) | $1.27 M(+240.9%) |
| Sept 2009 | - | $371.90 K(-57.2%) |
| June 2009 | - | $869.60 K(-47.8%) |
| Mar 2009 | - | $1.66 M(-29.5%) |
| Dec 2008 | $2.36 M(-2362.2%) | $2.36 M(-18.5%) |
| Sept 2008 | - | $2.90 M(-0.8%) |
| June 2008 | - | $2.92 M(-562.1%) |
| Mar 2008 | - | -$631.60 K(+505.6%) |
| Dec 2007 | -$104.30 K(-104.4%) | -$104.30 K(-123.0%) |
| Sept 2007 | - | $453.20 K(-7.2%) |
| June 2007 | - | $488.40 K(-63.0%) |
| Mar 2007 | - | $1.32 M(-44.2%) |
| Dec 2006 | $2.36 M | $2.36 M(+33.1%) |
| Sept 2006 | - | $1.78 M(-6.2%) |
| June 2006 | - | $1.89 M(-2117.3%) |
| Feb 2006 | - | -$93.80 K(+13.1%) |
| Nov 2005 | - | -$82.90 K(+11.6%) |
| Aug 2005 | - | -$74.30 K |
FAQ
- What is Cytosorbents annual stockholders equity?
- What is the all time high annual shareholders equity for Cytosorbents?
- What is Cytosorbents annual shareholders equity year-on-year change?
- What is Cytosorbents quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cytosorbents?
- What is Cytosorbents quarterly shareholders equity year-on-year change?
What is Cytosorbents annual stockholders equity?
The current annual shareholders equity of CTSO is $23.28 M
What is the all time high annual shareholders equity for Cytosorbents?
Cytosorbents all-time high annual stockholders equity is $79.22 M
What is Cytosorbents annual shareholders equity year-on-year change?
Over the past year, CTSO annual stockholders equity has changed by -$12.10 M (-34.20%)
What is Cytosorbents quarterly stockholders equity?
The current quarterly shareholders equity of CTSO is $13.00 M
What is the all time high quarterly shareholders equity for Cytosorbents?
Cytosorbents all-time high quarterly stockholders equity is $80.23 M
What is Cytosorbents quarterly shareholders equity year-on-year change?
Over the past year, CTSO quarterly stockholders equity has changed by -$5.51 M (-29.78%)